May 2, 2019
BD receives FDA approval for sterile CHG skin prep solution
Editor's Note
Becton, Dickinson and Company (BD) announced on April 30 that it had received Food & Drug Administration (FDA) approval for BD ChloraPrep skin preparation with sterile solution.
This new product is the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the US.
The FDA’s approval ensures the solution inside the applicator receives the same level of sterilization as the applicator, BD says.
Free Daily News
- 5 reasons why perioperative leaders deserve to attend the 2025 OR Manager Conference
- Global medical community rejects Trump’s Tylenol-autism claims: Statements compilation
- Surgery, implantable devices offer new hope for drug-resistant epilepsy
- Remote monitoring speeds recovery, lowers complications after cancer surgery
- Common supplements may heighten bleeding risk during surgery, Polish study finds
- Keeping sensory aids in place during surgery reduces delirium risk in older hip fracture patients
- HFMA warns affordability crisis is driving up provider bad debt
- Report warns sterile processing staffing crisis threatens surgical safety
- Ascension swings to profit as outpatient push, cost cuts take hold
- High BMI alone did not raise early complication risk after outpatient TJA
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement